Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Illustration demonstrating the Complex relationship between iron status and outcomes of STEMI
Complex relationship between iron status and outcomes of STEMI

A new paper has been published In Cardiovascular Research by the Lakhal-Littleton Group. In this translational study, the Lakhal-Littleton Group and their collaborators investigate the relationship between iron status and outcomes of myocardial infarction. In patients, they found that low circulating iron at admission independently predicts lower risk of major adverse cardiovascular events (MACE), such as heart failure, over 4.5 year follow-up. In mice, the researchers show that dietary iron restriction prior to myocardial infarction reduces the risk of progression to heart failure in the weeks that follow. Mechanistically, clinical and preclinical data support a role of iron in amplifying myocardial injury post MI. 

These discoveries caution against iron supplementation in patients with acute myocardial infarction, and point to iron chelation as a therapeutic strategy to limit myocardial injury and improve long-term outcomes.

Read the paper here